University of Oklahoma Health Sciences Center, 801 NE 13th St., Oklahoma City, OK, 73104, USA.
Vascular Biology Program and the Department of Surgery, Boston Children's Hospital, Boston, MA, 02115, USA.
Orphanet J Rare Dis. 2023 May 11;18(1):113. doi: 10.1186/s13023-023-02722-5.
Intestinal malrotation is a rare congenital condition with potentially devastating consequences due to potential volvulus and massive intestinal necrosis. Diagnosis is often delayed and long-term symptoms following surgical correction are poorly characterized. We developed the Intestinal Malrotation Patient Outcomes and WEllness Registry (IMPOWER), a national patient-generated registry (PGR), to capture data related to presenting symptoms, testing, diagnosis, treatment, and follow-up of individuals diagnosed with malrotation. IMPOWER captures patient-reported information from adult patients and parents/caregivers of children diagnosed with malrotation at the time of enrollment and at ongoing 6-month intervals. We present baseline characteristics of patients enrolled during the first two months of the registry.
Within the first two months, 354 patients with malrotation enrolled in IMPOWER, and 191 (53.9%) completed all baseline assessments. Nearly 90% of the 119 pediatric participants and 37.7% of the 72 adult participants experienced symptoms prior to diagnosis. Vomiting was the predominant symptom for pediatric participants compared to abdominal pain in adults. Yellow bilious emesis was more commonly reported than green, and volvulus at diagnosis occurred in 70% of pediatric and 27% of adult participants. One-third of pediatric participants had a bowel resection as part of their initial surgical procedure, resulting in 23.4% with diagnosed short bowel syndrome. More than 60% of pediatric and 80% of adult registrants reported gastrointestinal symptoms that persisted throughout the first year following their initial operation. Approximately 25% of registrants reported visiting four or more gastroenterologists for management of ongoing symptoms.
Fewer than half of pediatric patients presented with the "classic" presentation of green bilious colored emesis. Yellow bilious emesis was more commonly reported, and chronic gastrointestinal symptoms (i.e., abdominal pain, reflux, constipation, diarrhea) and feeding intolerance were common following surgical procedures for malrotation. This novel PGR highlights the need for a multicenter prospective registry to characterize the natural history and develop consistent standards of care related to the diagnosis, treatment, and long-term care for patients with malrotation.
肠旋转不良是一种罕见的先天性疾病,由于潜在的扭转和大量肠坏死,可能会产生严重的后果。诊断往往被延误,手术后的长期症状特征也很差。我们开发了肠旋转不良患者结局和健康登记(IMPOWER),这是一个全国性的患者生成登记(PGR),以收集与诊断为旋转不良的个体的症状、检查、诊断、治疗和随访相关的数据。IMPOWER 从成年患者和诊断为旋转不良的儿童的父母/照顾者在登记时和持续的 6 个月间隔期间,收集患者报告的信息。我们介绍了登记开始后两个月内登记的患者的基线特征。
在最初的两个月内,354 名肠旋转不良患者登记在 IMPOWER 中,其中 191 名(53.9%)完成了所有的基线评估。在 119 名儿科参与者中,近 90%和 72 名成人参与者中 37.7%在诊断前经历过症状。与成人相比,呕吐是儿科参与者的主要症状。与绿色相比,黄色胆汁性呕吐更为常见,70%的儿科患者和 27%的成人患者在诊断时发生了扭转。三分之一的儿科患者在初始手术中有肠切除,导致 23.4%的患者被诊断为短肠综合征。超过 60%的儿科和 80%的成人登记患者报告说,在最初手术后的第一年中,他们一直存在胃肠道症状。大约 25%的登记患者报告说,为了管理持续的症状,他们看了 4 个或更多的胃肠病医生。
不到一半的儿科患者出现了“典型”的绿色胆汁性呕吐表现。黄色胆汁性呕吐更为常见,旋转不良手术后,慢性胃肠道症状(即腹痛、反流、便秘、腹泻)和喂养不耐受很常见。这个新的 PGR 强调了需要一个多中心前瞻性登记来描述自然史,并制定与诊断、治疗和旋转不良患者的长期护理相关的一致标准。